c-Jun N-terminal kinase is involved in mercuric ions-mediated interleukin-4 secretion in mast cells

International Archives of Allergy and Immunology

Volumn 136, Issue 2, 2005, Pages 181-190

  Walczak Drzewiecka, Aurelia ^a   Wyczółkowska, Janina ^a   Dastych, Jarosław ^a  

^a INSTITUTE OF MEDICAL BIOLOGY   (Poland)

Author keywords

c Jun; c Jun N terminal kinase; Interleukin 4; Mast cell; Mercuric

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; INTERLEUKIN 4; MERCURY; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; ANTHRA(1,9 CD)PYRAZOL 6(2H) ONE; ANTHRA(1,9-CD)PYRAZOL-6(2H)-ONE; ANTHRACENE DERIVATIVE; ION; PROTEIN KINASE INHIBITOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; IN VITRO STUDY; MAST CELL; MOUSE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CULTURE TECHNIQUE; DRUG EFFECT; IMMUNOLOGY; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; ANTHRACENES; CELL CULTURE TECHNIQUES; INTERLEUKIN-4; IONS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAST CELLS; MERCURY; MICE; PROTEIN KINASE INHIBITORS; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 15844368092     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083892     Document Type: Article

References (44)

1. Bigazzi PE: Metals and kidney autoimmunity. Environ Health Perspect 1999;107(suppl 5):753-765.
2. Kanerva L, Jolanki R, Estlander T, Alanko K, Savela A: Incidence rates of occupational allergic contact dermatitis caused by metals. Am J Contact Dermat 2000;11:155-160.
3. Stejskal J, Stejskal VD: The role of metals in autoimmunity and the link to neuroendocrinology. Neuroendocrinol Lett 1999;20:351-364.
4. Mayes MD: Epidemiologic studies of environmental agents and systemic autoimmune diseases. Environ Health Perspect 1999;107:743-748.
5. 2 in the rat. J Immunol 1981;126:699-792.
6. Kiely PD, Gillespie KM, Oliveira DB: Oxpentifylline inhibits tumor necrosis factor-alpha mRNA transcription and protects against arthritis in mercuric chloride-treated brown Norway rats. Eur J Immunol 1995;25:2899-2906.
7. Pelletier L, Pasquier R, Vial MC, Mandet C, Montier R, Salomon JC, Druet P: Mercury-induced autoimmune glomerulonephritis: Requirement for T-cells. Nephrol Dial Transplant 1987;1:211-218.
8. Gillespie KM, Qasim FJ, Tibbatts LM, Thiru S, Oliveira DB, Mathieson PW: Interleukin-4 gene expression in mercury-induced autoimmunity. Scand J Immunol 1995;41:268-272.
9. Kiely PD, Pecht I, Oliveira DB: Mercuric chloride-induced vasculitis in the Brown Norway rat: Alpha beta T cell-dependent and -independent phases: Role of the mast cell. J Immunol 1997;159:5100-5106.
10. Bagenstose LM, Salgame P, Monestier M: Mercury-induced autoimmunity in the absence of IL-4. Clin Exp Immunol 1998;114:9-12.
11. Dastych J, Walczak-Drzewiecka A, Wyczolkowska J, Metcalfe DD: Murine mast cells exposed to mercuric chloride release granule-associated N-acetyl-beta-D-hexosaminidase and secrete IL-4 and TNF-alpha. J Allergy Clin Immunol 1999;103:1108-1114.
12. Oliveira DB, Gillespie K, Wolfreys K, Mathieson PW, Qasim F, Coleman JW: Compounds that induce autoimmunity in the brown Norway rat sensitize mast cells for mediator release and interleukin-4 expression. Eur J Immunol 1995;25:2259-2264.
13. 2-induced interleukin-4 gene expression in T cells involves a protein kinase C-dependent calcium influx through L-type calcium channels. J Biol Chem 1997;272:32411-32418.
14. Brown MA, Hural J: Functions of IL-4 and control of its expression. Crit Rev Immunol 1997;17:1-32.
15. Rooney JW, Hoey T, Glimcher LH: Coordinate and cooperative roles for NF-AT and AP-1 in the regulation of the murine IL-4 gene. Immunity 1995;2:473-483.
16. Macian F, Garcia-Rodriguez C, Rao A: Gene expression elicited by NFAT in the presence or absence of cooperative recruitment of Fos and Jun. Embo J 2000;19:4783-4795.
17. Pulverer BJ, Kyriakis JM, Avruch J, Nikolakaki E, Woodgett JR: Phosphorylation of c-Jun mediated by MAP kinases. Nature 1991;353:670-674.
18. Hibi M, Lin A, Smeal T, Minden A, Karin M: Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev 1993;7:2135-2148.
19. Kallunki T, Su B, Tsigelny I, Sluss HK, Derijard B, Moore G, Davis R, Karin M: JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation. Genes Dev 1994;8:2996-3007.
20. Ip YT, Davis RJ: Signal transduction by the c-Jun N-terminal kinase (JNK) - from inflammation to development. Curr Opin Cell Biol 1998;10:205-219.
21. Barr RK, Bogoyevitch MA: The c-Jun N-terminal protein kinase family of mitogen-activated protein kinases (JNK MAPKs). Int J Biochem Cell Biol 2001;33:1047-1063.
22. Turney KD, Parrish AR, Orozco J, Gandolfi AJ: Selective activation in the MAPK pathway by Hg(II) in precision-cut rabbit renal cortical slices. Toxicol Appl Pharmacol 1999;160:262-270.
23. Matsuoka M, Wispriyono B, Iryo Y, Igisu H: Mercury chloride activates c-Jun N-terminal kinase and induces c-Jun expression in LLC-PK1 cells. Toxicol Sci 2000;53:361-368.
24. Du J, Suzuki H, Nagase F, Akhand AA, Yokoyama T, Nakashima I: Mercuric chloride stimulates distinct signal transduction pathway for DNA synthesis in a T-cell line, CTLL-2. J Cell Biochem 2000;78:500-508.
25. Ishizuka T, Oshiba A, Sakata N, Terada N, Johnson GL, Gelfand EW: Aggregation of the FcepsilonRI on mast cells stimulates c-Jun amino-terminal kinase activity. A response inhibited by wortmannin. J Biol Chem 1996;271:12762-12766.
26. Garrington TP, Ishizuka T, Papst PJ, Chayama K, Webb S, Yujiri T, Sun W, Sather S, Russell DM, Gibson SB, Keller G, Gelfand EW, Johnson GL: MEKK2 gene disruption causes loss of cytokine production in response to IgE and c-Kit ligand stimulation of ES cell-derived mast cells. Embo J 2000;19:5387-5395.
27. Liu FT, Bohn JW, Ferry EL, Yamamoto H, Molinaro CA, Sherman LA, Klinman NR, Katz DH: Monoclonal dinitrophenyl-specific murine IgE antibody: Preparation, isolation, and characterization. J Immunol 1980;124:2728-2737.
28. Tsai M, Hunt J, Arm JP, London C, Gurish M, Galli SJ: The C1.MC/C57.1 (C57) mouse mast cell line is of BALB/c origin and is tumorigenic in BALB/c mice (abstract). FASEB J 1996;10:A1218.
29. Westwick JK, Brenner DA: Methods for analyzing c-Jun kinase. Methods Enzymol 1995;255:342-359.
30. Derijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, Karin M, Davis RJ: JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 1994;76:1025-1037.
31. Song JS, Haleem-Smith H, Arudchandran R, Gomez J, Scott PM, Mill JF, Tan TH, Rivera J: Tyrosine phosphorylation of Vav stimulates IL-6 production in mast cells by a Rac/c-Jun N-terminal kinase-dependent pathway. J Immunol 1999;163:802-810.
32. Tara D, Weiss DL, Brown MA: An activation-responsive element in the murine IL-4 gene is the site of an inducible DNA-protein interaction. J Immunol 1993;151:3617-3626.
33. Bruhn KW, Nelms K, Boulay JL, Paul WE, Lenardo MJ: Molecular dissection of the mouse interleukin-4 promoter. Proc Natl Acad Sci USA 1993;90:9707-9711.
34. Sirova M, Riha I, Rihova B: Limited T helper cell activity in C57BL/10 (B10) mice with inherited low IgG responsiveness. Scand J Immunol 1996;44:453-460.
35. Schroeder JT, Howard BP, Jenkens MK, Kagey-Sobotka A, Lichtenstein LM, MacGlashan DW Jr: IL-4 secretion and histamine release by human basophils are differentially regulated by protein kinase C activation. J Leukoc Biol 1998;63:692-698.
36. Hurst R, Schatz JR, Matts RL: Inhibition of rabbit reticulocyte lysate protein synthesis by heavy metal ions involves the phosphorylation of the alpha-subunit of the eukaryotic initiation factor 2. J Biol Chem 1987;262:15939-15945.
37. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, Bhagwat SS, Manning AM, Anderson DW: SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 2001;98:13681-13686.
38. Han Z, Boyle DL, Chang L, Bennett B, Karin M, Yang L, Manning AM, Firestein GS: c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Invest 2001;108:73-81.
39. Brown MA, Pierce JH, Watson CJ, Falco J, Ihle JN, Paul WE: B cell stimulatory factor-1/interleukin-4 mRNA is expressed by normal and transformed mast cells. Cell 1987;50:809-818.
40. Plaut M, Pierce JH, Watson CJ, Hanley-Hyde J, Nordan RP, Paul WE: Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores. Nature 1989;339:64-67.
41. Bradding P, Feather IH, Howarth PH, Mueller R, Roberts JA, Britten K, Bews JP, Hunt TC, Okayama Y, Heusser CH, et al: Interleukin 4 is localized to and released by human mast cells. J Exp Med 1992;176:1381-1386.
42. Metcalfe DD, Baram D, Mekori YA: Mast cells. Physiol Rev 1997;77:1033-1079.
43. Ochel M, Vohr HW, Pfeiffer C, Gleichmann E: IL-4 is required for the IgE and IgG1 increase and IgG1 autoantibody formation in mice treated with mercuric chloride. J Immunol 1991;146:3006-3011.
44. van Vliet E, Uhrberg M, Stein C, Gleichmann E: MHC control of IL-4-dependent enhancement of B cell Ia expression and Ig class switching in mice treated with mercuric chloride. Int Arch Allergy Immunol 1993;101:392-401.